GlassScriptPhysician profile
Bunthan B Dee
NPI 1497887251
$2,518.16
in general payments reported to CMS, 2019-2025
13 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $568 · 2021: $660 · 2022: $469 · 2023: $250 · 2024: $19.66 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $636.95 | 2019-2025 | Grafix Pl, Oasis, Stravix Pl |
| Cardiovascular Systems INC. | $634.46 | 2020-2022 | |
| Melinta Therapeutics, LLC | $499.88 | 2022-2023 | Kimyrsa |
| Zyla Life Sciences, INC. | $351.86 | 2019-2020 | |
| Nalu Medical, INC. | $135.13 | 2025 | Nalu Neurostimulation System |
| Terumo Medical Corporation | $105.99 | 2021 | |
| Zimmer Biomet Holdings, INC. | $33.33 | 2019 | |
| Horizon Therapeutics Plc | $30.67 | 2020 | |
| Assertio Therapeutics, INC. | $27.22 | 2020 | |
| Tactile Systems Technology INC | $19.66 | 2024 | Flexitouch Plus, Entre Plus |
| Amgen INC. | $16.15 | 2025 | Krystexxa |
| Resmed Corp | $14.68 | 2022 | |
| Linvatec Corporation | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bunthan Dee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.